• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干粉吸入器载体的机械加工对药物雾化性能的影响。

The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.

作者信息

Young Paul M, Chan Hak-Kim, Chiou Herbert, Edge Stephen, Tee Terence H S, Traini Daniela

机构信息

Advanced Drug Delivery Group, Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia.

出版信息

J Pharm Sci. 2007 May;96(5):1331-41. doi: 10.1002/jps.20933.

DOI:10.1002/jps.20933
PMID:17455362
Abstract

The influence of processing on the performance of carrier material used in dry powder inhalers was investigated. alpha-Lactose monohydrate crystals were processed by ball milling for cumulative time durations and their properties evaluated. As expected, milling reduced the median particle diameter while increasing fine particulate (<10 microm) and amorphous levels. Recrystallization of these partially amorphous samples resulted in a reduction in fines, elimination of amorphous material with little change in median diameter. To study the effects of processing on aerosolization performance, blends of lactose monohydrate with a model drug (nedocromil sodium trihydrate), were evaluated using an in vitro multistage liquid impinger (MSLI) model. In general, milling and storage of the carriers at high humidity (prior to blending) had a significant (ANOVA, p < 0.05) effect on the fine particle fractions (FPF; <6.8 microm). These effects were attributed predominantly to the fines content, showing a strong correlation between increased fines and FPF (R(2) = 0.974 and 0.982 for milled and recrystallized samples, respectively). However, this relationship only existed up to 15% fines concentration, after which agglomerate-carrier segregation was observed and FPF decreased significantly. These results suggest that, after processing, high-dose drug formulation performance is dominated by the presence of fines.

摘要

研究了加工过程对干粉吸入器中所用载体材料性能的影响。对α-乳糖一水合物晶体进行了不同累积时长的球磨处理,并对其性能进行了评估。正如预期的那样,球磨减小了中位粒径,同时增加了细颗粒(<10微米)和无定形物的含量。这些部分无定形样品的重结晶导致细粉减少,无定形物质消除,而中位直径变化不大。为了研究加工过程对雾化性能的影响,使用体外多级液体撞击器(MSLI)模型对乳糖一水合物与一种模型药物(三水合奈多罗米钠)的混合物进行了评估。一般来说,载体在高湿度下(混合前)进行球磨和储存对细颗粒分数(FPF;<6.8微米)有显著影响(方差分析,p<0.05)。这些影响主要归因于细粉含量,细粉增加与FPF之间存在很强的相关性(研磨和重结晶样品的R²分别为0.974和0.982)。然而,这种关系仅在细粉浓度达到15%之前存在,之后观察到团聚体与载体分离,FPF显著下降。这些结果表明,加工后,高剂量药物制剂的性能主要受细粉存在的影响。

相似文献

1
The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.干粉吸入器载体的机械加工对药物雾化性能的影响。
J Pharm Sci. 2007 May;96(5):1331-41. doi: 10.1002/jps.20933.
2
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
3
Effect of milling and sieving on functionality of dry powder inhalation products.研磨和筛分对干粉吸入产品功能的影响。
Int J Pharm. 2006 Feb 17;309(1-2):51-9. doi: 10.1016/j.ijpharm.2005.10.043. Epub 2005 Dec 27.
4
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.用标准夹带管从含有一水乳糖的药物混合物中产生的干粉气雾剂:1. 硫酸沙丁胺醇和二钠色甘酸钠。
J Pharm Sci. 2010 Aug;99(8):3398-414. doi: 10.1002/jps.22107.
5
Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol.决定奈多罗米钠作为干粉气雾剂性能的物理化学因素。
J Pharm Sci. 2000 Sep;89(9):1160-9. doi: 10.1002/1520-6017(200009)89:9<1160::aid-jps8>3.0.co;2-d.
6
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.干粉吸入剂中的空气分级器技术(ACT) 第4部分。Novolizer多剂量干粉吸入器中空气分级器技术的性能。
Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25.
7
Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.用乙醇-丙酮二元混合物结晶得到的乳糖制备硫酸沙丁胺醇,可改善其气溶胶化性能。
J Pharm Sci. 2011 Jul;100(7):2665-84. doi: 10.1002/jps.22483. Epub 2011 Jan 25.
8
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.
9
Dispersibility of lactose fines as compared to API in dry powders for inhalation.与吸入用干粉中的原料药相比,乳糖细粉的分散性。
Int J Pharm. 2016 May 17;504(1-2):27-38. doi: 10.1016/j.ijpharm.2016.03.004. Epub 2016 Mar 7.
10
Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.丙酸氟替卡松和硫酸特布他林干粉制剂中乳糖级别的影响。
Int J Pharm. 2012 Jan 17;422(1-2):75-82. doi: 10.1016/j.ijpharm.2011.10.030. Epub 2011 Oct 20.

引用本文的文献

1
Advancing pulmonary therapy: the role of dry powder inhalation technology in lung disease management.推进肺部治疗:干粉吸入技术在肺部疾病管理中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 5. doi: 10.1007/s00210-025-04305-6.
2
Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations.吸入式口服药品的扩大生产及批准后变更:科学与监管考量
J Aerosol Med Pulm Drug Deliv. 2025 Apr;38(2):39-63. doi: 10.1089/jamp.2024.0036. Epub 2024 Dec 9.
3
Preparation and Evaluation of Inhalable Amifostine Microparticles Using Wet Ball Milling.
使用湿球磨法制备可吸入氨磷汀微粒及其评价
Pharmaceutics. 2023 Jun 9;15(6):1696. doi: 10.3390/pharmaceutics15061696.
4
Physical stability of dry powder inhaler formulations.干粉吸入剂制剂的物理稳定性。
Expert Opin Drug Deliv. 2020 Jan;17(1):77-96. doi: 10.1080/17425247.2020.1702643. Epub 2019 Dec 13.
5
Effect of Lactose Pseudopolymorphic Transition on the Aerosolization Performance of Drug/Carrier Mixtures.乳糖假多晶型转变对药物/载体混合物雾化性能的影响。
Pharmaceutics. 2019 Nov 4;11(11):576. doi: 10.3390/pharmaceutics11110576.
6
Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.微粉化材料中粉末亚群存在的证据:雾化粉末的空气动力学粒径级分具有独特的物理化学性质。
Pharm Res. 2014 Dec;31(12):3251-64. doi: 10.1007/s11095-014-1414-3.
7
The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.甘露醇-乳糖混合物对干粉吸入器性能的影响。
Pharm Res. 2012 Aug;29(8):2139-56. doi: 10.1007/s11095-012-0743-3. Epub 2012 Apr 5.
8
Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.二碘酞酸纳米颗粒团聚体干粉气溶胶作为肺部造影剂。
Int J Pharm. 2010 May 31;391(1-2):305-12. doi: 10.1016/j.ijpharm.2010.03.009. Epub 2010 Mar 7.
9
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.通过可控纳米颗粒团聚制备的联合化疗干粉气雾剂。
Pharm Res. 2009 Jul;26(7):1752-63. doi: 10.1007/s11095-009-9886-2. Epub 2009 May 5.
10
Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution.布地奈德纳米颗粒团聚体作为干粉气溶胶,具有快速溶解的特点。
J Pharm Sci. 2009 Aug;98(8):2731-46. doi: 10.1002/jps.21630.